1. Woolf A.D., Pfleger B. Burden of major musculoskeletal conditions. Bull. World Health Organ. 2003; 81(9): 646-56
2. Titova L.V. Struktura revmaticheskikh zabolevanii u rabochikh lesoderevoobrabatyvayushchei promyshlennosti. Vestnik Vserossiiskogo nauchno-issledovatel'skogo instituta mekhanizatsii zhivotnovodstva. 1988; (1): 10.
3. Balabanova R.M., Amirdzhanova V.N., Nasonov E.L. Primenenie genno-inzhenernykh biologicheskikh preparatov pri revmatoidnom artrite v Rossiiskoi Federatsii. Nauchno-prakticheskaya revmatologiya. 2012; 50(6): 10-4.
4. Chichasova N.V. Lechenie boli u bol'nykh osteoartrozom razlichnoi lokalizatsii. Lechashchii vrach. 2014; (7): 2-7.
5. Smolen J.S., Landewé R., Breedveld F.C., Buch M., Burmester G., Dougados M., et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. 2014; 73(3): 492-509